Articles |

Introduction* FREE TO VIEW

Paul A. Bunn, Jr, MD
Author and Funding Information

*From the Lung Cancer Program and Departments of Medicine, University of Colorado Cancer Center, Denver, CO.

Correspondence to: Paul A. Bunn Jr, MD, University of Colorado Cancer Center, Box B-188, 4200 East 9th Ave, Denver, CO 80262; e-mail: paul.bunn@uchsc.edu

Chest. 2000;117(4_suppl_1):71S. doi:10.1378/chest.117.4_suppl_1.71S
Text Size: A A A
Published online

(CHEST 2000; 117:71S)

Lung cancer is the most common cause of cancer death for both men and women in the United States, and it is a growing worldwide problem, especially in developing countries. In the past, there were few good options for the early detection, prevention, or treatment of lung cancer. This led to considerable pessimism regarding the care of patients with the disease. In the recent past, however, there have been many advances in the biology, early detection, staging, prevention, and treatment of lung cancer that are bringing about a reassessment of the nihilistic attitude of physicians toward lung cancer patients. For the optimal care of lung cancer patients, these advances require a multimodality approach to detection, staging, prevention, and therapy. These advances are summarized in this supplement, based on the proceedings of the Multimodality Approach to Lung Cancer symposium, held in Vail, Colorado.




Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
Como International Conference Position Statement*: Lung Cancer Screening for Early Diagnosis 5 Years After The 1998 Varese Conference
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543